EUCTR2017-003958-16-NL进行中（未招募）1 期
Effect of Reslizumab on small airways in asthma. RESSAPEA
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 入组人数
- 33
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Blood eosinophil counts =0.4 x 10E9/L despite adequate treatment with high doses of inhaled corticosteroids (>800mcg/day fluticaone equivalent)
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 22
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 11
排除标准
- •Eosinophilic Diseases: Subjects with other conditions that could lead to elevated eosinophils such as Hyper eosinophilic Syndromes, including Churg-Strauss Syndrome, or Eosinophilic Esophagitis.
研究者
相似试验
招募中
4 期
Effect of Reslizumab on small airways in asthma. RESSAPEAair trapping10006436AsthmaNL-OMON55433Academisch Medisch Centrum33
尚未招募
不适用
Effect of Reslizumab on small airways in asthma - RESSAPEANL-OMON29078Amsterdam University Medical Centre, University of Amsterdam33
进行中（未招募）
1 期
TARGETTargeting the small airways in asthma”MedDRA version: 17.0Level: PTClassification code 10003553Term: AsthmaSystem Organ Class: 10038738 - Respiratory, thoracic and mediastinal disordersAsthmaEUCTR2013-001143-31-DKBispebjerg University Hospital40
尚未招募
不适用
An exploratory study to assess the effect of benralizumab on small airway obstruction in patients with severe asthma using functional respiratory imagingasthmaNL-OMON26915Ciro20
进行中（未招募）
1 期
Reslizumab in patients with severe asthma who failed to respond to omalizumabSevere asthmaMedDRA version: 19.1Level: PTClassification code 10003553Term: AsthmaSystem Organ Class: 10038738 - Respiratory, thoracic and mediastinal disordersEUCTR2016-004459-65-ESRespira. Fundación Española del Pulmón (SEPAR)